<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85029303153</prism:url><dc:identifier>SCOPUS_ID:85029303153</dc:identifier><eid>2-s2.0-85029303153</eid><prism:doi>10.1038/natrevmats.2017.56</prism:doi><article-number>17056</article-number><dc:title>Tools for translation: Non-viral materials for therapeutic mRNA delivery</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><citedby-count>13</citedby-count><prism:publicationName>Nature Reviews Materials</prism:publicationName><dc:publisher>Nature Publishing Group</dc:publisher><source-id>21100812243</source-id><prism:issn>20588437</prism:issn><prism:volume>2</prism:volume><prism:coverDate>2017-09-12</prism:coverDate><openaccess/><openaccessFlag/><dc:creator><author seq="1" auid="57195618657"><ce:initials>K.A.</ce:initials><ce:indexed-name>Hajj K.A.</ce:indexed-name><ce:surname>Hajj</ce:surname><ce:given-name>Khalid A.</ce:given-name><preferred-name><ce:initials>K.A.</ce:initials><ce:indexed-name>Hajj K.</ce:indexed-name><ce:surname>Hajj</ce:surname><ce:given-name>Khalid A.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57195618657</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>Â© 2017 Macmillan Publishers Limited,part of Springer Natur.</publishercopyright><ce:para>In recent years, messenger RNA (mRNA) has come into the spotlight as a versatile therapeutic with the potential to prevent and treat a staggering range of diseases. Billions of dollars have been invested in the commercial development of mRNA drugs, with ongoing clinical trials focused on vaccines (for example, influenza and Zika viruses) and cancer immunotherapy (for example, myeloma, leukaemia and glioblastoma). Although significant progress has been made in the design of in vitro-transcribed mRNA that retains potency while minimizing unwanted immune responses, the widespread use of mRNA drugs requires the development of safe and effective drug delivery vehicles. In this Review, we provide an overview of the field of mRNA therapeutics and describe recent advances in the development of synthetic materials that encapsulate and deliver mRNA payloads.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85029303153" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85029303153&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85029303153&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author seq="1" auid="57195618657"><ce:initials>K.A.</ce:initials><ce:indexed-name>Hajj K.A.</ce:indexed-name><ce:surname>Hajj</ce:surname><ce:given-name>Khalid A.</ce:given-name><preferred-name><ce:initials>K.A.</ce:initials><ce:indexed-name>Hajj K.</ce:indexed-name><ce:surname>Hajj</ce:surname><ce:given-name>Khalid A.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57195618657</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="2" auid="35609935600"><ce:initials>K.A.</ce:initials><ce:indexed-name>Whitehead K.A.</ce:indexed-name><ce:surname>Whitehead</ce:surname><ce:given-name>Kathryn A.</ce:given-name><preferred-name><ce:initials>K.A.</ce:initials><ce:indexed-name>Whitehead K.</ce:indexed-name><ce:surname>Whitehead</ce:surname><ce:given-name>Kathryn A.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/35609935600</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></authors></abstracts-retrieval-response>